Darabi et al. found that circulating miR-21 levels and matrix metalloproteinase-9 (MMP-9) were significantly higher in acute coronary syndrome (ACS) patients compared with stable coronary artery disease patients. This evidence concerns the gene MMP9 and coronary artery disorder.